Home
>
National Drug Code (NDC)
>
BOOSTRIX
BOOSTRIX - 58160-842-51 - (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
Drug Information of BOOSTRIX
| Product NDC: | 58160-842 |
| Proprietary Name: | BOOSTRIX |
| Non Proprietary Name: | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| Active Ingredient(s): | 8; 2.5; 8; 5; 2.5 ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL & nbsp; Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BOOSTRIX
| Product NDC: | 58160-842 |
| Labeler Name: | GlaxoSmithKline Biologicals SA |
| Product Type: | VACCINE |
| FDA Application Number: | BLA125106 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090724 |
Package Information of BOOSTRIX
| Package NDC: | 58160-842-51 |
| Package Description: | 10 SYRINGE in 1 CARTON (58160-842-51) > .5 mL in 1 SYRINGE (58160-842-41) |
NDC Information of BOOSTRIX
| NDC Code | 58160-842-51 |
| Proprietary Name | BOOSTRIX |
| Package Description | 10 SYRINGE in 1 CARTON (58160-842-51) > .5 mL in 1 SYRINGE (58160-842-41) |
| Product NDC | 58160-842 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| Dosage Form Name | SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20090724 |
| Marketing Category Name | BLA |
| Labeler Name | GlaxoSmithKline Biologicals SA |
| Substance Name | BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Strength Number | 8; 2.5; 8; 5; 2.5 |
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL |
| Pharmaceutical Classes | Inactivated Clostridium Tetani Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Tetanus Toxoid [Chemical/Ingredient],Inactivated Corynebacterium Diphtheriae Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Diphtheria Toxoid [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Pertussis Vaccine [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pertussis Vaccine [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pertussis Vaccine [Chemical/Ingredient] |
